Award
National Institute of Arthritis and Musculoskeletal and Skin Diseases 5U01AR083132-03
Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty – a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial)
Recipient
University of Michigan at Ann Arbor
Award Amount
$1,109,271.00
Ceiling
$1,109,271.00
Awarded
August 28, 2025
Identifier
5U01AR083132-03
NIH-funded clinical trial to assess cannabidiol for reducing opioid use after knee surgery, awarded to University of Michigan at Ann Arbor.
Description
A NIH-funded clinical trial project conducted by the University of Michigan at Ann Arbor, focusing on evaluating CBD as an opioid-sparing medication post-surgery in primary total knee arthroplasty. The project duration is from September 18, 2023, to August 31, 2028.